These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4299667)
1. [Apropos of the pathogenesis of myasthenia gravis]. Dolzhenko AT Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(3):393-8. PubMed ID: 4299667 [No Abstract] [Full Text] [Related]
2. Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies. Namba T Arch Neurol; 1972 Feb; 26(2):144-50. PubMed ID: 4332732 [No Abstract] [Full Text] [Related]
3. Some aspects of myasthenia gravis. Grashchenkov N; Perelman LB Ann N Y Acad Sci; 1966 Jan; 135(1):398-408. PubMed ID: 4287549 [No Abstract] [Full Text] [Related]
4. The diagnosis and management of myasthenia gravis. Walsh JC Med J Aust; 1974 Jun; 1(25):997-1001. PubMed ID: 4369281 [No Abstract] [Full Text] [Related]
6. [The Grob test in myasthenia: discussion of an atypical case]. Gambi D; Tonali P Riv Neurol; 1971; 41(3):161-9. PubMed ID: 4331238 [No Abstract] [Full Text] [Related]
7. Pathogenesis of myasthenia gravis. Br Med J; 1971 Apr; 2(5752):1-2. PubMed ID: 5550865 [No Abstract] [Full Text] [Related]
8. [Some metabolic and regulatory aspects in myasthenia]. Hrazdira CL; Vágner B Cesk Neurol; 1968 Jul; 31(4):280-5. PubMed ID: 4306025 [No Abstract] [Full Text] [Related]
9. Pharmacology of myasthenia gravis. Dipalma JR Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763 [No Abstract] [Full Text] [Related]
10. The use of ACTH and corticosteroids in myasthenia gravis. Genkins G; Kornfeld P; Osserman KE; Namba T; Grob D; Brunner NG Ann N Y Acad Sci; 1971 Sep; 183():369-74. PubMed ID: 4330763 [No Abstract] [Full Text] [Related]
12. Adverse interaction between corticosteroid hormones and anticholinesterase drugs. Patten BM; Oliver KL; Engel WK Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943 [No Abstract] [Full Text] [Related]
14. [Effects of incomplete ligation of the nerve on neuromuscular mechanism--appearance of myasthenic pheomenon]. Shibuya N Rinsho Shinkeigaku; 1975 May; 15(5):279-85. PubMed ID: 1238218 [No Abstract] [Full Text] [Related]
15. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)]. Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548 [No Abstract] [Full Text] [Related]
16. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome]. Andreis I; Lovnićki TJ; Beara N; Taradi M Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205 [TBL] [Abstract][Full Text] [Related]
17. Unravelling the pathogenesis of myasthenia gravis. Vincent A Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217 [TBL] [Abstract][Full Text] [Related]
18. Severe occult juvenile myasthenia gravis responsive to long-term corticosteroid therapy. Griggs RC; McFarlin DE; Engel WK Trans Am Neurol Assoc; 1968; 93():216-8. PubMed ID: 4304254 [No Abstract] [Full Text] [Related]